Short answer
biote Corp. (BTMD) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $44M (down 9.5% year over year) with net income of −$7M.
Q2 2026 key financials · XBRL
- Revenue
- $44M
- −9.5% YoY · −1.6% QoQ
- Net income
- −$7M
- −306.1% YoY · −388.2% QoQ
- Operating margin
- -7.9%
- EPS (diluted)
- −$0.20
- −322.2% YoY · −433.3% QoQ
Source: XBRL data from the biote Corp. (BTMD) Q2 2026 10-Q on SEC EDGAR. USD.
biote Corp. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Credit risk: amended Credit Agreement dated May 8, 2026, with Truist Bank as administrative agent
- Capital allocation risk: $4.8 million spent repurchasing 2,436,177 shares during the quarter
- Liquidity risk: approximately $5.2 million remaining under the share repurchase authorization
- Management continuity risk: Robert C. Peterson serving simultaneously as interim CEO, CFO, and chief business officer
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other biote Corp. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.